WELCOME TO ADD4KIDS: ACCELERATING DEMAND-DRIVEN TOOLS FOR PAEDIATRIC INNOVATION ADOPTION IN EUROPE!

THE
PROJECT

The project will create a holistic innovation action plan in paediatrics to ensure optimal implementation and utilisation of demand-driven innovation financing instruments to support the adoption of paediatric innovation in a coordinated manner across Europe. Through these means, the project will reduce the uncertainty and risk of paediatric innovations and create synergies with existing initiatives to ensure maximal adoption amongst member states, hereby strengthening competitiveness to optimise the innovation potential of the European paediatric sector.

IDENTIFY

current demand-driven financing instruments and mechanisms for the adoption of paediatric innovative solutions

COLLECT DATA

on the needs and challenges in the adoption of paediatric innovation faced by different ecosystem stakeholders

BENCHMARK

best-practices and specific characteristics that must be taken into account when designing innovative financing instruments for paediatric healthcare innovations

DEVELOP

working groups of diverse stakeholders to ideate solutions that address the needs, challenges and adhere to defined characteristics

BUILD

a European action plan to fast-track the adoption of paediatric innovation solutions using existing and new demand-driven instruments within an interconnected paediatric innovation ecosystem

OBJECTIVES

ADD4KIDS can be instrumental to enable widespread access to paediatric innovations and contribute to the health and wellbeing of children across Europe and beyond. Our vision is to correct the mismatch between the availability of novel, patient-centric paediatric innovations and the adoption of these within healthcare systems to reach clinicians and patients, as well as reduce the innovation adoption gap that is so prevalent in paediatric healthcare.

ADD4KIDS’ main objective is to create a holistic paediatric innovation action plan to ensure optimal adoption of demand-driven financing instruments and vehicles for paediatric innovation across Europe, collaborating with all principal actors of the ecosystem to create multi-stakeholder action plan to ultimately impact children’s health and well-being.

To bring innovative solutions to all children and health systems, disparities between EU countries in paediatric innovation adoption must be dissipated. All countries should be facilitators of all the paediatric innovation potential that resides in their ecosystem. This will be achieved only if cross-border, inclusive networks and demand-driven financing initiatives are promoted.

PARTNERS

The ADD4KIDS consortium brings together a multidisciplinary group of eight partners from across Europe, offering:

DIVERSE LEVELS OF INNOVATION

Widening countries, leading innovation countries and moderate innovation countries

GEOGRAPHIC SPREAD

Representation from northern, eastern, and southern Europe and Israel.

QUADRUPLE HELIX

With partners representing industry, society, research and government

RELEVANT EXPERIENCE

In designing, establishing and running networks, needs analysis, technology transfer and strategic planning.

Institut de Recerca Sant Joan de Déu – Fundació Sant Joan de Déu (FSJD-CERCA) acts as the coordinator of ADD4Kids. Its mission is to contribute to the improvement of the health and wellbeing of people by fostering, supporting and managing the research and innovation activities of Barcelona Children’s Hospital Sant Joan de Déu (HSJD, affiliated entity to FSJD-CERCA in the project) and other linked organisations. FSJD-CERCA currently participates in 28 EU-funded research projects, coordinating 8 of them.

Barcelona Children’s Hospital Sant Joan de Déu HSJD is the largest and the most renowned children’s hospital in Spain and one of the most recognized of its category across Europe, being ranked as the third European medical centre of its kind by volume of activity. HSJD is the leader of the i4KIDS initiative. As a university hospital, HSJD represents patients, health care professionals and research within the scope of paediatric innovation.

EIT Health (Institute of Innovation and Technology) is the largest European Network in the field of innovation and health based on pillars of education, business creation and research. As a partner in the project, it is uniquely positioned to promote the adoption of innovative strategies and mindsets in paediatric healthcare professionals and stakeholders throughout Europe, with previous publications in the optimisation of innovation pathways, as well as paths to European harmonisation in healthcare. EIT Health’s network includes more than 150 world-class partner organisations across Europe. We have regional innovation hubs located throughout Europe that are closely interconnected. Our participation in the consortium will be fundamental to co-create a European Action Plan for fast-tracking the adoption of innovation in paediatric. Leveraging of our experience in supporting programmes from the education, innovation and business acceleration pillar and provide support to the dissemination, communication and extending the reach throughout our network.

The Children’s Memorial Health Institute (IPCZD) is the largest and best-equipped institute of paediatric healthcare in Poland, also serving as one of the leading teaching hospitals. IPCZD has participated in EPTRI, a project that proposed novel developmental models for a future research infrastructure in paediatric medicines, and ECHO, which offers community-based healthcare providers with access to evidence-based knowledge and an interprofessional network. Thus, IPCZD has experience in identifying the needs and challenges associated with paediatric healthcare and leveraging collective groups to ideate solutions.

Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) is a public entity of the Catalan Department of Health whose primary mission is to generate scientific and relevant knowledge to contribute to the improvement of the quality, safety, and sustainability of the healthcare system by facilitating the decision-making process. AQuAS Innovation Area coordinates and participates in national and international projects that promote innovation adoption across the different levels of the Catalan health system. In this area AQuAS is also actively boosting the deployment of instruments of innovation adoption as Public Procurement of Innovation, Pre-Commercial Procurement instruments and Social Impact Bonds. One of the key methodologies employed by AQuAS is the involvement of people and ecosystem stakeholders in its processes, which will be brought forth in ADD4Kids to maximise the impact of results. Having previously coordinated and contributed to several innovation adoption projects (public procurement of innovation, precommercial procurement, education programmes, community of practice and innovation adoption, as: DECIPHER (PCP, GA: 288028), UNWIRED HEALTH (PCP; GA: 610753); THALEA (PCP, GA: 611855); INSPIRE Campus (CSA, GA: 611714); ENIGMA (PCP, GA 612226); STOPandGO (PPI, GA: 621013), PRO4VIP (CSA, GA: 645584), MAGIC (PCP, GA: 687228), ANTISUPERBUGS (PCP, GA 688878), THALEA2 (PPI, GA: 689041), STARS (PCP, GA: 727585), RITMOCORE (PPI, GA 727796)); VALUE (PGA: 20328), EURIPHI (CSA, GA: 825922);PiPPi (CSA, GA: 826157); EcoQUIP Plus (PPI, GA:857790), oncNGS (PCP, GA: 874467), TIQUE (PCP, GA: 965356), PROCURA (PCP, Intereg SUDOE), HARMONICS (PGA: 220134), SAVE-COR (PGA: 220385) and Can.Heal (CSA, GA: 101080009)), AQuAS can bring its experience of accompanying the demand- and supply-side actors from across borders to develop an alignment between healthcare needs’, healthcare solutions, and procurement possibilities.

SCIENSANO is the national Institute of Public Health of Belgium and the central federal institution for public health research. SCIENSANO supports national initiatives in food security, medicine quality testing including vaccines, biosafety assessment, and quality assessment of laboratories (both medical as microbial). With respect to personalized medicine and cancer in particular for pediatrics, SCIENSANO hosts the Cancer Centre, the national body for monitoring and evaluating the national cancer policy. The Cancer Centre leads a national initiative on bringing innovative molecular diagnostics to patients in close collaboration with all involved health professionals, the governmental responsible and the cancer registry.

The European Children’s Hospitals Organisation (ECHO) is the only pan-European organisation representing children’s hospitals. With a broad geographic reach, ECHO members include leaders in research, innovation, and care of children and young people with complex conditions from across the continent and Israel. ECHO is built on collaboration and is experienced in bringing members and other stakeholders together to work on common challenges.

Inveniam Group is a consultancy focused on bridging the gap between innovation and the market, with sectoral focus in life sciences and sustainability. INV supports actors during the technology transfer process, working closely to appropriately select specific technologies from their portfolios, based on the technologies’ applications, value proposition, likelihood of success and market potential. INV has worked on several projects to support the creation of regional hubs and ecosystems in Europe and South America. Furthermore, INV has participated in 6 European projects, 3 CSAs, coordinating 1, while also authoring a European Commission report on Non-Participation of ICT SMEs in European Research Programmes.

How can we help you from i4KIDS-EUROPE?

If you want to contact us, please fill in this form. We will be really pleased to know from you!